Benjamin Bonavida – författare

Overcoming Cancers Resistant to HER-2 Antibodies

Targeting Cell Survival Pathways to Enhance Response to Chemotherapy

Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy

Nitric Oxide (Donor/Induced) in Chemosensitization

Role of Nutraceuticals in Cancer Chemosensitization

Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders

Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy

Improving the Therapeutic Ratio in Head and Neck Cancer

Prognostic and Therapeutic Applications of RKIP in Cancer

YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer

A Critical Therapeutic Target

Successes and Challenges of NK Immunotherapy

Breaking Tolerance to Cancer Resistance

Nitric Oxide in Health and Disease

Therapeutic Applications in Cancer and Inflammatory Disorders

Therapeutic Applications of Nitric Oxide in Cancer and Inflammatory Disorders

Third International Conference on Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders

Hypoxia-induced Tumor Heterogeneity and Immune Evasion

Clinical Interventions

Nitric Oxide (NO) and Cancer

Prognosis, Prevention, and Therapy

Nitric Oxide (NO) and Cancer

Prognosis, Prevention, and Therapy

Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy

Targeted Therapies to Reverse Resistance

Resistance to Immunotherapeutic Antibodies in Cancer

Strategies to Overcome Resistance

Resistance to Immunotherapeutic Antibodies in Cancer

Strategies to Overcome Resistance

Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy

Targeted Therapies to Reverse Resistance

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy

Nitric Oxide and Cancer: Pathogenesis and Therapy

Resistance to Immunotoxins in Cancer Therapy

Resistance of Cancer Cells to CTL-Mediated Immunotherapy

Nitric Oxide and Cancer: Pathogenesis and Therapy